Showing results (21-30 of 159) with videos related to

Sort By:
Pageof 16
Nature Medicine|August 20, 2003
A new genetic method to generate and isolate small, short-lived but highly potent dendritic cell-tumor cell hybrid vaccinesVy Phan, Fiona Errington, S Chiat Cheong, et al.
The Journal of Clinical Investigation|April 6, 2010
Antiangiogenic cancer therapy combined with oncolytic virotherapy leads to regression of established tumors in miceTimothy Kottke, Geoff Hall, Jose Pulido, et al.
Oncoimmunology|March 14, 2013
Improving the outcome of adoptive cell transfer by targeting tumor escapeKaren M Kaluza, Richard Vile
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 28, 2015
Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune ResponsesKarishma Rajani, Christopher Parrish, Timothy Kottke, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 28, 2011
Precise scheduling of chemotherapy primes VEGF-producing tumors for successful systemic oncolytic virotherapyTimothy Kottke, John Chester, Elizabeth Ilett, et al.
Plastic and Reconstructive Surgery|January 29, 2015
Adenovirally delivered enzyme prodrug therapy with herpes simplex virus-thymidine kinase in composite tissue free flaps shows therapeutic efficacy in rat models of gliomaRohit Seth, Aadil A Khan, Timothy D Pencavel, et al.
Cancer Gene Therapy|January 11, 2003
The oncolytic virotherapy treatment platform for cancer: unique biological and biosafety points to considerRichard Vile, Dale Ando, David Kirn
Nature Biotechnology|March 20, 2012
Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanomaJose Pulido, Timothy Kottke, Jill Thompson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 12, 2013
Functional cloning of recurrence-specific antigens identifies molecular targets to treat tumor relapseNicolas Boisgerault, Timothy Kottke, Jose Pulido, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Cyclophosphamide facilitates antitumor efficacy against subcutaneous tumors following intravenous delivery of reovirusJian Qiao, Hongxun Wang, Timothy Kottke, et al.
Pageof 16